July 6, 2026 · Form 4 insider transaction
Boulding Mark Elliott bought 2,266 shares of PTC Therapeutics, Inc. at $39.42 per share, a transaction worth $89.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025.